155 related articles for article (PubMed ID: 37917375)
41. The role of glutathione detoxification pathway in MCLR-induced hepatotoxicity in SD rats.
Li S; Chen J; Xie P; Guo X; Fan H; Yu D; Zeng C; Chen L
Environ Toxicol; 2015 Dec; 30(12):1470-80. PubMed ID: 24964298
[TBL] [Abstract][Full Text] [Related]
42. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximine.
Carmichael J; Friedman N; Tochner Z; Adams DJ; Wolf CR; Mitchell JB; Russo A
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1191-3. PubMed ID: 3744939
[TBL] [Abstract][Full Text] [Related]
44. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
45. Knockdown of glutamate cysteine ligase catalytic subunit by siRNA causes the gold nanoparticles-induced cytotoxicity in lung cancer cells.
Liu M; Zhao Y; Zhang X
PLoS One; 2015; 10(3):e0118870. PubMed ID: 25789740
[TBL] [Abstract][Full Text] [Related]
46. The effect of buthionine sulfoximine on the glutathione level in goldfish tissues.
Lushchak VI; Hermes-Lima M
Ukr Biokhim Zh (1999); 2005; 77(3):35-8. PubMed ID: 16566126
[TBL] [Abstract][Full Text] [Related]
47. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
48. Depletion of glutathione by L-buthionine sulfoximine does not promote inactivation of myo-inositol transport in cultured bovine lens epithelial cells.
Cammarata PR; Tse D; Yorio T
Curr Eye Res; 1991 Apr; 10(4):321-30. PubMed ID: 1676962
[TBL] [Abstract][Full Text] [Related]
49. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
Gallagher EP; Hasspieler BM; Di Giulio RT
Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
[TBL] [Abstract][Full Text] [Related]
50. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
[TBL] [Abstract][Full Text] [Related]
51. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma.
Palomares T; Bilbao P; del Olmo M; Castro B; Calle Y; Alonso-Varona A
Melanoma Res; 1999 Jun; 9(3):233-42. PubMed ID: 10465578
[TBL] [Abstract][Full Text] [Related]
52. Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion.
Harris IS; Endress JE; Coloff JL; Selfors LM; McBrayer SK; Rosenbluth JM; Takahashi N; Dhakal S; Koduri V; Oser MG; Schauer NJ; Doherty LM; Hong AL; Kang YP; Younger ST; Doench JG; Hahn WC; Buhrlage SJ; DeNicola GM; Kaelin WG; Brugge JS
Cell Metab; 2019 May; 29(5):1166-1181.e6. PubMed ID: 30799286
[TBL] [Abstract][Full Text] [Related]
53. Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2.
Reber U; Wüllner U; Trepel M; Baumgart J; Seyfried J; Klockgether T; Dichgans J; Weller M
Biochem Pharmacol; 1998 Feb; 55(3):349-59. PubMed ID: 9484802
[TBL] [Abstract][Full Text] [Related]
54. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
55. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
Shrieve DC; Harris JW
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
[TBL] [Abstract][Full Text] [Related]
56. Increasing glutathione levels by a novel posttranslational mechanism inhibits neuronal hyperexcitability.
Sri Hari A; Banerji R; Liang LP; Fulton RE; Huynh CQ; Fabisiak T; McElroy PB; Roede JR; Patel M
Redox Biol; 2023 Nov; 67():102895. PubMed ID: 37769522
[TBL] [Abstract][Full Text] [Related]
57. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
58. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
Duechler M; Stańczyk M; Czyz M; Stepnik M
Cancer Chemother Pharmacol; 2008 Apr; 61(5):727-37. PubMed ID: 17594095
[TBL] [Abstract][Full Text] [Related]
59. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
60. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
